(Q39371714)

11 September 2017

Optimization of prostate carcinoma staging: comparison of imaging and clinical methods (English)

1 reference

11 September 2017

1 reference

Huch Böni RA

1

1 reference

11 September 2017

Boner JA

2

1 reference

11 September 2017

Debatin JF

3

1 reference

11 September 2017

Trinkler F

4

1 reference

11 September 2017

Knönagel H

5

1 reference

11 September 2017

Von Hochstetter A

6

1 reference

11 September 2017

Helfenstein U

7

1 reference

11 September 2017

Krestin GP

8

1 reference

11 September 2017

1 September 1995

1 reference

11 September 2017

1 reference

11 September 2017

50

1 reference

11 September 2017

593-600

1 reference

11 September 2017

9

1 reference

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Current role of MR imaging in the staging of adenocarcinoma of the prostate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Clinical stage B prostate carcinoma: staging with MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Prostate: MR imaging with an endorectal surface coil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Prostate cancer: local staging with endorectal surface coil MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Inflatable surface coil for MR imaging of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Comparison of the digital rectal examination, endorectal ultrasound, and body coil magnetic resonance imaging in the staging of adenocarcinoma of the prostate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

MR imaging of the prostate gland: normal anatomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

The value of serum prostate specific antigen determinations before and after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2805%2983287-8

10.1016/S0009-9260(05)83287-8

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference